| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |